Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer to shutter six out of 20 R&D sites
Marketwatch
Monday, November 9, 2009 - 3:13pm
tags:
Pfizer, reorganization, R&D
Ranbaxy: FDA Issues Will Take Long Time To Resolve
WSJ Online
Monday, November 9, 2009 - 11:26am
tags:
India, Ranbaxy, FDA, Daiichi Sankyo
Enzon sells specialty drug business for $300M
Yahoo/AP
Monday, November 9, 2009 - 11:24am
tags:
Enzon, M&A, Sigma-Tau
Insurers, Drugmakers Turn to Senate for Health-Bill Changes
Bloomberg
Monday, November 9, 2009 - 11:24am
tags:
healthcare reform, healthcare bill
200 pharma whistleblowers in line for court
Fierce Pharma
Monday, November 9, 2009 - 11:22am
tags:
whistleblowers
Xoma Waffles on Timing of Drug Partnership
TheStreet.com
Monday, November 9, 2009 - 11:20am
tags:
Xoma, XOMA 052
Pfizer Aiming for 30,900 Layoffs Through 2012
BNET Pharma
Monday, November 9, 2009 - 10:27am
tags:
Pfizer, layoffs
Despite Omeros Flop, Trius and Other Biotech IPO Hopefuls Might Fare Better
BNET Pharma
Monday, November 9, 2009 - 10:25am
tags:
IPOs, Trius Therapeutics, Omeros
Forest Laboratories: Steady Growth in Sales and Earnings
Seeking Alpha
Monday, November 9, 2009 - 10:13am
tags:
Forest Labs, earnings
Cephalon's Upside and Downside
Seeking Alpha
Monday, November 9, 2009 - 10:12am
tags:
Cephalon, Teva Pharmaceuticals, Watson Pharmaceuticals
XenoPort and Glaxo says FDA review of neuropathic pain drug extended 3 months, to Feb. 2010
Yahoo/AP
Monday, November 9, 2009 - 10:09am
tags:
XenoPort, FDA, GSK, neuropathic pain
D.C. Vaccine Conference: Why Investors Should Stay Tuned
Seeking Alpha
Monday, November 9, 2009 - 10:07am
tags:
vaccines, Abbott Laboratories, Merck, Novartis, Sanofi Pasteur, Cel-Sci, Ibis, EpiVax, Immunovaccine, Advaxis
Elan, Biogen change Tysabri label due to PML risk
Reuters
Monday, November 9, 2009 - 10:06am
tags:
Elan, Biogen Idec, Tysabri, PML, MS
Pfizer Broke the Law by Promoting Drugs for Unapproved Uses
Bloomberg
Monday, November 9, 2009 - 10:03am
tags:
Pfizer, off-label, Bextra
House, Senate Health-Care Legislation: Side-by-Side Comparison
Bloomberg
Monday, November 9, 2009 - 10:02am
tags:
healthcare reform, healthcare bill
Alcon Boosts Presence In Eye Disease Market
Yahoo/Investors Business Daily
Monday, November 9, 2009 - 10:00am
tags:
eye disease, Alcon
Boston Scientific Sets $296 Million Settlement on Devices
WSJ Online
Monday, November 9, 2009 - 9:59am
tags:
medical devices, Boston Scientific, settlements
No Product Revenues, Plenty of Risk: Buy Exelixis?
CNBC
Monday, November 9, 2009 - 9:58am
tags:
Exelixis, GSK, Bristol-Myers Squibb, Sanofi, Roche, Genentech
China Is Growth Market for Novartis
Seeking Alpha
Sunday, November 8, 2009 - 12:57pm
tags:
Novartis, China
Chinese co to fund D-Pharm Phase III trial
Globes, Israel
Sunday, November 8, 2009 - 12:55pm
tags:
D-pharm, Wanbang Biopharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.